WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Amylyx Pharmaceuticals revenue was -$1.27M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AMLX annual revenue was $87.4M, with -77.1% growth year-over-year.

AMLX revenue history

Current Revenue
-$1.3M
Current Earnings
-$218.9M
Current Profit Margin
17,205.7%

Be the first to know when AMLX announces revenue.

AMLX Revenue History By Year

AMLX Yearly RevenueAMLX RevenueAMLX ChangeAMLX Revenue Growth
2024-12-31$87.37M-$293.42M-77.06%
2023-12-31$380.79M$358.56M+1,612.94%
2022-12-31$22.23M$21.95M+7,700.00%
2021-12-31$285.00k-$365.00k-56.15%
2020-12-31$650.00k-$776.00k-54.42%
2019-12-31$1.43MN/AN/A

1 of 1

Amylyx Pharmaceuticals Revenue FAQ

What was AMLX's revenue last quarter?

On Invalid Date, Amylyx Pharmaceuticals (NASDAQ: AMLX) reported Q1 2025 revenue of $0.00 up 100% year over year. In the same quarter last year, Amylyx Pharmaceuticals's revenue was $88.64 million.

What was Amylyx Pharmaceuticals's revenue in 2024?

Amylyx Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $87.37 million, a 77.06% decrease year over year.

How much does Amylyx Pharmaceuticals make in a day?

Based on Amylyx Pharmaceuticals annual revenue for the past five years, AMLX makes an average of $269,217.53 per day.

What was Amylyx Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Amylyx Pharmaceuticals's revenue has grown null year over year. Amylyx Pharmaceuticals's revenue in the past year totaled -$1.27 million.

How much does Amylyx Pharmaceuticals make in a year?

Amylyx Pharmaceuticals's revenue by year for the past five years is:
  • Amylyx Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $87.37 million, a 77.06% decrease year over year.
  • Amylyx Pharmaceuticals's annual revenue for Dec 31, 2023 was $380.79 million, a 1,612.94% increase from 2022.
  • Amylyx Pharmaceuticals's annual revenue for 2022 was $22.23 million, a 7,700% increase from 2021.
  • Amylyx Pharmaceuticals's annual revenue for 2021 was $285.00 thousand, a 56.15% decrease from 2020.
  • Amylyx Pharmaceuticals's annual revenue for 2020 was $650.00 thousand, a 54.42% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.